Liu Mei-jun, Zhou Wen-hua, Zhao Jing, Cui Wen-Peng. Research advances of trimethylamine N-oxide and chronic kidney diseases[J]. Journal of Clinical Nephrology, 2021, 21(7): 602-607. DOI: 10.3969/j.issn.1671-2390.y20-116
    Citation: Liu Mei-jun, Zhou Wen-hua, Zhao Jing, Cui Wen-Peng. Research advances of trimethylamine N-oxide and chronic kidney diseases[J]. Journal of Clinical Nephrology, 2021, 21(7): 602-607. DOI: 10.3969/j.issn.1671-2390.y20-116
    shu

    Research advances of trimethylamine N-oxide and chronic kidney diseases

      Graphical Abstract
      • Abstract
    • Trimethylamine N-oxide(TMAO) is an important gut microbiota-dependent metabolite.Currently many clinical studies have confirmed the correlation between TMAO and the prognosis of chronic kidney disease(CKD) patients.This review summarized the latest researches of TMAO on the quality-of-life and mortality of CKD over the past decade.Finally the therapeutic strategy of reducing the plasma TMAO level was elaborated for preventing the further development of CKD and improving its survival rate.
      • FullText(HTML)
    • loading
      • References (53)
      • Related Articles

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return